01555nam 2200349 450 991068846550332120230701012010.0(CKB)5400000000044834(NjHacI)995400000000044834(EXLCZ)99540000000004483420230701d2020 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierMetformin /Anca Pantea Stoian, Manfredi Rizzo, editorLondon :IntechOpen,2020.1 online resource (242 pages)1-83880-760-8 The book "Metformin" aims to bring to light new concepts and trends related to the many metformin therapeutic features. After a history of over 60 years, with moments of decline and spectacular returns, metformin can now be regarded as a universal panacea, the valences of its therapeutics being increasingly appreciated, both in the background treatment of diabetes and pre-diabetes, but also in reproductive pathology, cancer, cardiovascular disease, and antiageing. In this respect, the mechanisms of action and the pharmacodynamics of metformin seem to be incompletely known, a number of current studies have revealed new action valences.MetforminMetformin.615.3Rizzo ManfrediStoian Anca PanteaNjHacINjHaclBOOK9910688465503321Metformin1952071UNINA